Viewing Study NCT02767661

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:38 PM
Ignite Modification Date: 2026-02-24 @ 10:56 AM
Study NCT ID: NCT02767661
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-16
First Post: 2016-05-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer
Sponsor: Sun Yat-sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metronomic capecitabine View
None aromatase inhibitor View
None first line treatment View
None metastatic breast cancer View